Descriptor-based methods of electrochemically measuring an analyte as well as devices, apparatuses and systems incorporating the same

Patent metadata

Field	Value
Publication number	US-11237128-B2
Application number	US-201916364340-A
Country	US
Kind code	B2
Filing date	Mar 26, 2019
Priority date	Mar 15, 2013
Publication date	Feb 1, 2022
Grant date	Feb 1, 2022

Abstract

Methods are disclosed for measuring an analyte concentration in a fluidic sample. Such methods allow one to correct and/or compensate for confounding variables such as hematocrit, salt concentration and/or temperature before providing an analyte concentration. The measurement methods use response information from a test sequence having at least one DC block, where DC block includes at least one excitation pulse and at least one recovery pulse, and where a closed circuit condition of an electrode system is maintained during the at least one recovery pulse. Information encoded in the excitation and recovery pulses are used to build within- and across-pulse descriptors to correct/compensate for hematocrit, salt concentration and/or temperature effects on the analyte concentration. Methods of transforming current response data also are disclosed. Further disclosed are devices, apparatuses and systems incorporating the various measurement methods.

First claim

The invention claimed is:

1. A method of electrochemically measuring glucose concentration in a fluid sample, the method comprising the steps of:
applying an electrical test sequence to an electrochemical biosensor, the biosensor comprising:
an electrode system,
a reagent in electrical communication with the electrode system, and
a receptacle configured to contact the fluid sample provided to the biosensor, with the fluid sample in fluidic contact with the reagent, wherein the test sequence comprises at least one DC block, the at least one DC block includes at least one excitation potential pulse and at least one recovery potential pulse, each potential configured to produce response information to the test sequence, and wherein a closed circuit condition of the electrode system is maintained during the at least one DC block;

measuring the response information from the test sequence; and
determining the glucose concentration of the fluid sample based at least in part upon descriptors built from encoded magnitude and shape characteristics of the response information to the test sequence, wherein the descriptors encode transformed excitation current response information and transformed recovery current response information, and wherein the determining is further based at least in part upon the transformed excitation current response information and the transformed recovery current response information.

2. The method of claim 1 further comprising the step of transforming the excitation current response information and the recovery current response information from a first x-y space, where x=time and y=current to a second x-y space where x=In(time) and y=In(current).

3. The method of claim 1 , wherein the determining the glucose concentration step is based upon an effective current determined based upon the transformed excitation current response information and the transformed recovery current response information.

4. The method of claim 3 , wherein the determined glucose concentration is a predicted glucose concentration, Predglu, determined in accordance with the equation:
Predglu=a0+(b0+exp(b1+b2*I eff +P eff +Y eff ))*(I eff ), where a0, b0, b1, and b2 are constants, P eff is an effective phase and Y eff is an effective admittance, wherein P eff is determined in accordance with the equation:
P eff =bp2*(p11*cos(α)+p12*sin(α))+bp3*(−p11*sin(α)+p12*cos(α)), where α=arctan(1), p11 is a 20 kHz AC phase, p12 is a 10 kHz AC phase, and bp2 and bp3 are weighting terms, and wherein Y eff is determined in accordance with the equation:
Y eff =by2*(y11*cos(α)+y12*sin(α))+by3*(−y11*sin(α)+y12*cos(α)), where α=arctan(1), y11 is a 20 kHz AC admittance, y12 is a 10 kHz AC admittance, and by2 and by3 are weighting terms.

5. The method of claim 1 , wherein 95% of the determined glucose concentrations fall within ±10 mg/dl of a reference at concentrations less than about 75 mg/dL, and wherein 95% of the determined glucose concentrations fall within ±10% of the reference at concentrations greater than or equal to about 75 mg/dL.

6. The method of claim 1 , wherein the determined glucose concentration has a standard deviation of normalized error (SDNE) of 5% or less.

7. The method of claim 1 , wherein the determined glucose concentration has a total system error (TSE) of 10% or less.

Assignees

• Roche Diabetes Care Inc

Inventors

• Carpenter Scott E
• Pan zheng zheng

Classifications

• G01N27/3274 Primary

  Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration (coding of calibration information G01N33/48771) · CPC title

• G01N27/4163

  checking the operation of, or calibrating, the measuring apparatus (G01N27/3274, G01N27/4175 and G01N33/0006 take precedence) · CPC title